Ikena Oncology - 4 Year Stock Split History | IMA | MacroTrends

Precious Metals

Ikena Oncology - 4 Year Stock Split History | IMA

Stock split history for Ikena Oncology since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

Ikena Oncology Annual Stock Splits

Ikena Oncology Quarterly Stock Splits

Sector	Industry	Market Cap	Revenue
Medical	MED-BIOMED/GENE	$0.061B	$0.009B
Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.

Stock Name	Country	Market Cap	PE Ratio
Velo3D (VLDXD)	United States	$0.089B	0.00
Kirkland's (TBHC)	United States	$0.031B	0.00
Mullen Automotive (BINI)	United States	$0.000B	0.00

We Need Your Support!

Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.

If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. We have provided a few examples below that you can copy and paste to your site:

Link Preview	HTML Code (Click to Copy)
Ikena Oncology - 4 Year Stock Split History \| IMA
Macrotrends
Source

Your image export is now complete. Please check your download folder.

We Need Your Support!

Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.

If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. We have provided a few examples below that you can copy and paste to your site:

Link Preview	HTML Code (Click to Copy)
Ikena Oncology - 4 Year Stock Split History \| IMA
Macrotrends
Source

Your data export is now complete. Please check your download folder.